Gynecology Conferences 2019 | Women Health | Obstetrics | Midwifery | Ob Nursing Events | USA | Europe | Middle East Meetings | Japan | Canada

Quick Links

Infertility and Donor Conception: Pregnancy is Just the Beginning!

Ultrasound in Female Infertility : 2D and CD

Theme: Focus on Next Generation & to Improve the Obstetrics & Gynecology Care

Gynecology 2019

Conference Program

Renowned Speakers

Olena Grechanina
Kharkiv Interregional Specialized Medical Genetic Center
Ukraine

P D Gupta
Manipal University,
India

Anjali Pal
All India Institute of Medical Sciences Raipur,
India

Pushpawati Thakur
AIIMS, Raipur,
India

Rita Rani
Mahavir Cancer Sansthan and Research Centre,
India

Alka Garg
Carewell Hospital,
India

Harwinder Kaur Cheema
Punjab Institute of Medical Sciences, Jalandhar,
India

Parul Nigam
St. Judeâ€™s Hospital, Jhansi,
India

Mais Ali-Saleh
Carmel Medical Center,
Israel

Sevgi Ozkan
Pamukkale University of Denizli,
Turkey

Pinar Sercekus Ak
Pamukkale University,
Turkey

Kathleen Kenney-Riley
Mercy College
USA

Brian Keevil
University Hospital of South Manchester
UK

Alex Ferenczy
McGill University
Canada

Moustafa K Eissa
Cyberjaya University College of Medical Sciences
Malaysia

Jianyu Rao
University of California
USA

Franco Maria Buonaguro
Istituto Nazionale Tumori
Italy

Donna Vine
University of Alberta
Canada

Taher H. Khalil
The Hormonal Disorders Specialty
UAE

Robert W. Tygenhof
Integrative Medical Group of IrvineEx:
USA

Tamer Rizk
Sulaiman Alhabib Medical Group
Saudi Arabia

Farhad Kamali
Newcastle University
UK

Fredy Ariza Cadena
Universidad ICESI and Universidad del Valle
Colombia

Dr DanCMartin
Obstetrician-gynecologist in Memphis, Tennessee
USA

Elliot M Levine
Obstetrician-gynecologist in Chicago, Illinois
USA

George Peery
Dean University of Texas USA
USA

Kwong-Kwok-Wong
University of Texas, USA
USA

Lei-Huo
The University of Texas , USA
USA

Linda Isaacs
Nutritional Research and Educational Foundation, USA
USA

Magda Johanna Vandeloo
Hasselt University, Belgium
Belgium

Magdalena Klink
Polish Academy of Sciences, Poland
Poland

Manjeet Rao
University of Texas , USA
USA

Marike Gabrielson
Karolinska Institutet, Sweden
Sweden

Maria E Sales
University of Buenos Aires , Argentina
Argentina

Marta Recio Rodriguez
University of Madrid, Spain
Spain

Martin Kristensson
Visiopharm , Denmark
Denmark

Matin Burrow
DMB Diagnostics GmbH, Germany
Germany

Megan McNeil
North Carolina State University
USA

Concepcion Diaz Arrastia
Rutgers Medical School in Piscataway, New Jersey
USA

Melissa Joyner
University of Texas
USA

Michaela Huynh
University of Texas
USA

Michael Friedrich
HELIOS Hospital
USA

Michael Retsky
Harvard TH Chan School of Public Health
USA

Muthusamy Thangaraju
Georgia Regents University
USA

Nichola C Garbett
University of Louisville
USA

Pascalen A Cohen
University of Lyon
France

Gwyn Richardson
Gynecologic oncologist in Galveston, Texas
USA

Gynecology 2019

Conference Series is esteemed to invite you to join the 6th International Conference on Gynecology and Obestetrics [GYNECOLOGY 2019] will be held during November 14-15, 2019 at Paris, France. Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Conference Series Organizes 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

The Theme of the conference is “Divulging the Future Aspects of Gynecology and Obstetrics”. Gynecology 2019 is a world class conference, where renowed international speakers, specialists will take concurrent sessions of infertility, assisted contraception, reproductive medicine, latest innovation in the field of gynecologic and obstetrics pathology.

The conference has been carefully designed so as to acknowledge the various recent researches going on in the field of gynecology and obstetrics. In addition to the paper presentations, the conference will provide its attendees to attend sessions of presentations and debates, workshops and symposiums as well as poster presentations. This conference on Gynecology 2019 will deal with various tracks from the different fields of Reproductive Health | Women health. The congress provides you with an unique opportunity to meet up with peers from both industry and academia. We co-ordinally invite all concerned people to come and join us at our event and make it a successful one by your esteem participation.

A vast array of topics will be discusses in the congress which includes Pre & Post Partum Care, Gynecologic Oncology, Urogynecology, Contraception, Donor Conception, Ethics & Psychology in reproductive medicine, Reproductive Endocrinology and Medicine, Cervical Cancer, Latest Innovation in Gynecological Pathology and Breast Disease & Management. At Conference series, it is our ideology to bring maximum exposure to our attendees, so we make sure the event is a blend which covers professionals such as gynecologists, obstetricians, midwifes, nurses, pathologists, veteran researchers, women healthcare professionals from academia & industry making the conference an enriching valley of information and experience.

Attendees Outlook?

· Obstetrics and Gynecologists

· Clinicians

· Executives

· Researchers

· Information and communication technology vendors and consultants

· Women & Healthcare innovators and entrepreneurs

· International delegates

· Specialists in IVF

· IVF Centers

· Gynecological Pathologists

· Gynecological Oncologists

· Directors of Maternity Hospitals

· Endocrinologists

· Infertility specialists

· Heads of the Obstetrics & Gynecology Departments

· Nursing scholars

· Students of Medicine Disciplines

· Upcoming Researchers

· Pharmacists

· Anesthesiologist

· Family Medicine Physicians and General practitioners

· Clinical Toxicologists

· IVF Associations and Societies

Why Participate?

· Share your ideas, expertise, successes and challenges with colleagues from across the world

· Meet and learn from other attendees with common interests

· Earn CME & CPD credits

Learning Objective:

Participation in Obstetrics and Gynecology 2019 will provide all attendees with opportunities to hear and discuss:

· Cutting edge ideas

· Technology solutions

· Innovations

· New strategies

Women's Top 5 Health Concerns

There are a lot of issues that women face these days. But here, we will be talking about the most important concerns related to their life!

Heart Disease

Heart disease is the leading killer of both men and women. It has been analyzed in women, the condition is responsible for about 29% of deaths.

Yet death in itself isn't the biggest problem for women with heart disease. The real trouble is in premature death and disability.

Although more men die of heart disease than women, females tend to be underdiagnosed, often to the point that it's too late to help them once the condition is discovered.

"The symptoms for women are typical for women, and they are often missed by doctors and the patient themselves."

Breast Cancer

Breast cancer is the most common cancer in women. It is second to lung cancer as the leading cause of death for women.

The American Cancer Society lists the following as risk factors for breast cancer:

· Increasing age

· Genes (Most commonly, the BRCA1 and BRCA2 genes).

· Family history of the disease (Pedigree)

· Personal history of the disease

· Race. White women have a slightly greater risk of getting breast cancer compared with African-American women. Yet African-Americans have had a greater chance of dying from this disease.

· Earlier abnormal breast biopsy

· Frequent earlier chest radiation

· Early onset of menstruation (before age 12) or menopause after age 55

· Not having children

· Medication use, such as diethylstilbestrol (DES)

· Too much alcohol

· Obesity

Osteoporosis

Hunched backs, back pain, and frailty used to be things older women had to accept before doctors knew anything more about osteoporosis. There are steps women and girls can take to avoid such problems.

Osteoporosis is largely preventable; the behaviors that women develop in their childhood, in their adolescence, and in their early adult years really play a significant role in the development of the disease. That's because bodies build up most of bone mass until age 30. Then new bone stops forming, and the focus is on maintenance of old bone.

Depression

Depression appears to affect more women than men. It has been reported that about 12 million women are affected by a depressive disorder each year compared to about 6 million men.

Autoimmune Diseases

Autoimmune diseases are a group of disorders in which the immune system attacks the body and destroys or alters tissues. There are more than 80 serious chronic illnesses in this category, including lupus, multiple sclerosis, and type 1 diabetes.

To know more join us @ Gynecology and Obstetrics International Conference scheduled during November 14-15, 2019 at Paris, France

Track 1: Gynecology & Obstetrics

Throughout each phase of your lifecycle: Wellness, sickness and times of change, we must be vigilant about your healthcare. Gynecology deals with any disease concerning the reproductive organs: fallopian tubes, cervix, uterus, ovaries and vagina. A gynecologist may also treat related problems in the urinary system since these are closely related to female reproductive organs. The obstetrician refers to the complications of childbirth and ensures both mother and baby is safely guided through all of the phases of pregnancy and childbirth. Both gynecologist & obstetrician play a vital role in the women health. Women need reproductive health care during every stage of life and concern with gynecologist is the first step towards comprehensive, ongoing health and wellness management. Researcher’s focused on overcoming infertility, improving health care for both non-pregnant and pregnant women, combating gynecologic cancers, and easing the menopausal transition in women and many more.

4th International Conference on Reproductive Health and Medicine, April 23-24, 2019 | Berlin, Germany; 9th World Congress on Breast Cancer, April 25-26,2019 London, UK; 9th World Congress on Breast Cancer & Therapies, April 29-30, 2019 Kyoto, Japan; 4th International Conference on Nursing & Midwifery, May 17-18, 2019 Philadelphia, USA; 27th Cancer Nursing & Nurse Practitioners Conference, July 11-12 2019, Vienna, Austria; 34th International Conference on Oncology Nursing and Cancer Care, July 29-30, 2019 Melbourne, Australia; 6th Asia Pacific Gynecology and Obstetrics Congress, July 26-27, 2019 Melbourne, Australia; Annual Midwifery and Pediatric Nursing Congress, August 12-13, 2019 Abu Dhabi, UAE; 6th World Congress on Midwifery & Women’s Health, September 09-10, 2019 Baltimore, USA.

Track 2: Midwifery

Midwifery is an eclectic field and is professional in gynecology and Number of Research institutes working on the Midwifery are approximately 20 or more as well as some universities are giving training to women to be midwifery and most of midwives are women, total number of universities are approximately 70 which are working on midwives and the funding is around $20000- $30000 and Academia 50% , 40% industry and Others 30% are included in this topic. Midwife is a profession in obstetrics as well. The term midwife is used in refers for both women and men. In Many International & National Gynecology Conferences or Events around the world has included the advancements of Midwifery and has proved to be an essential topic, as per the definition of the WHO and the International Federation of Gynecology and Obstetrics: A Midwife is a person who is regularly admitted to a midwifery educational program that is recognized in the country in which it is located, and who has successfully completed the stipulated course of studies in midwifery and has obtained the essential qualifications to be registered and legally licensed to practice midwifery.

Track 3: Maternal-Fetal Medicine

A Maternal-Fetal Medicine (MFM) is refer to an Ob-Gyn physician who has completed an additional two to three years of education and training. They are high-risk pregnancy experts. For, MFM specialists work to keep the woman as healthy as possible while her body changes and her baby grows. MFM specialists also deal with the care for women who face unexpected and health problems that develop during pregnancy, such as early labor, bleeding, or high blood pressure.
Their training includes a four-year residency in obstetrics and gynecology followed by a three-year fellowship. They may provide treatments, prenatal tests, and perform surgeries. They refer as physician during lower-risk pregnancies and the primary obstetrician in especially high-risk pregnancies. After birth, they act as a pediatricians or neonatologists. For the mother, perinatologists assist with pre-existing health concerns, as well as complications caused by pregnancy.

Track 4: Urogynecology

Urogynecology is a professional in gynecology and the number of International & National research institutes working on the Urogynecology are approximately 40 or more and some universities also give training to women on Urogynecology, total number of universities which focus on this area are approximately 60 and also obtain a funding of around $20000- $30000 and includes 10% industry, 20% of academia and Others 70% .It is a surgical sub-specialty of urology and gynecology. Urogynecology is also referred as a subspecialty of Female Pelvic Medicine. Urogynecology includes diagnosis and treatment of urinary problem and female pelvic floor disease.

Track 5: Gynecological Endocrinology

There are many Research institutes working on the Gynecological Endocrinology which are approximately 35 and the Number of Universities working on this topic are approximately 80 and funding for the research given by University or a research institute is around $10000 - $30000 including Academia 20%, 30% industry and Others 50%. Gynecological Endocrinology focuses on the treatment of disorders related to menstruation, fertility and menopause. Reproductive endocrinology and Fetal-Placental neuroendocrine development refer to a subspecialty that focuses on the biological causes and its interventional treatment of infertility and its development.

Track 6: Gynecological Oncology

As discussed in many Gynecologic events and meetings occurring in the worldwide, it is stated that around 70,000 women are diagnosed with gynecologic cancers in the USA, and half of those were uterine cancer diagnoses with deaths of 7,000 women per year. Ovarian cancer is found to be the 2nd most common gynecologic cancer with around 24,000 new cases every year, leading to 17,000 deaths per year. Mortality of cases in cervical cancer have been decreased as Pap smears have become common in place. however, there are about 11,000 diagnoses every year in which about 4,400 women die from this disease every year. 4,300 women are being diagnosed with vulvar cancer each year, in which there is about 900 deaths among them. Vaginal cancer account for about 2,500 diagnoses each year causing about 800 deaths. Every woman is at risk a gynecologic cancer. It is estimated that there will be around 97,000 new cases diagnosed and approximately causing 35,000 deaths from gynecologic cancers in the USA during the year 2015 stated as per The American Cancer Society, in which Uterine cancer may have the large portion of about 60% cases with an estimated mortality rate of approximately 18%. The Ovarian cancer has the highest mortality rate at 60%.

Track 7: Reproductive Medicine

Reproductive Medicine in Gynecology is ever growing area, Target audience are of Academia 20%, 50% industry and 30% of others. Reproductive medicine is a branch of medicine which focuses on prevention, diagnosis and management of the reproductive problems. The aim emphasizes to improve or maintain reproductive health and allowing people to have children at a time of their choice as discussed in many gynecology events occurring in worldwide. It is mainly focused on knowledge of reproductive physiology, anatomy and endocrinology which also relevant to the molecular biology, biochemistry and pathology. Regenerative medicine includes on process of replacing and regenerating human cells, tissues or organs to restore normal function.

Track 8: Prenatal Diagnosis

Prenatal Diagnosis is a part of gynecology. It refers to the testing for diseases or conditions in a fetus or embryo before the child is born. Target audience are of 40% industry, Academia 20% and 40% of others. Diagnostic testing can be performed by many invasive or non-invasive methods. As discussed in several gynecology events worldwide, the aim of this is to detect birth defects for examples neural tube defects, Down syndrome, genetic disorders, chromosome disorder and other genetic disorders such as sickle cell anemia , spina bifida, Tay Sachs disease, cystic fibrosis, Muscular dystrophy, cleft palate, thalassemia, and fragile X syndrome. Non-invasive techniques include examinations of the woman's womb by using ultrasonography and maternal serum screens

. Track 9: Family Planning

The critical step in the management of world population includes Contraception and Family planning measures. The world is distinguishing a huge vault over in the development of recent contraceptive technologies and assisted reproductive technologies such as achieving pregnancy in procedures like in vitro fertilization , artificial insemination and surrogacy to fight issues like infertility and its assessment. As discussed in several gynecology events High-risk patients include patients with diseases like hypertension, Sexually transmitted diseases, diabetes and other complications and the advancing trends in contraception and technologies will render a crucial role in regulating a large number of Reproductive Health indicators.

Track 10: Menopause

Menopause is well known concept in Gynecology. The number of Research institutes working on Menopause concepts are about 40-50 and the number of Universities are approximately 250 which are consisting menopause topics in the department of Gynecology and the funding towards the research on this topic is in between the figures of $30000 - $50000 ,Target audience are of about 20% in the industry, Academia 40% and 40% of others. Menopause is also known as the climacteric, which is the time in most women's lives where the menstrual periods stop permanently, and she will be no longer able to have children.

Track 11: Infertility

Infertility occur when a couple unable to conceive after having regular unprotected sex.
In the United States, around 20 percent of women aged 16 to 45 years are estimated to have difficulty conceiving or staying pregnant. Worldwide, 9 to 12 percent of couples’ experience fertility problems. Between 46 and 51 percent of cases are thought to stem from factors that affect the man. There are some causes genetic factor, age, smoking, diet, alcohol, mental stress. There are some treatments or medication which cure the infertility problem such as chemotherapy, radiation therapy& Non-steroidal anti-inflammatory drugs.

Track 12: Health-Related Behaviors in Women

The critical step in the management of world population includes Contraception and Family planning measures. The world is distinguishing a huge vault over in the development of recent contraceptive technologies and assisted reproductive technologies such as achieving pregnancy in procedures like in vitro fertilization , artificial insemination and surrogacy to fight issues like infertility and its assessment. As discussed in several gynecology events high-risk patients include patients with diseases like hypertension, Sexually transmitted diseases, diabetes and other complications and the advancing trends in contraception and technologies will render a crucial role in regulating a large number of Reproductive Health indicators.

Track 13: Sexual and Reproductive Health and Rights

Women’s sexual and regenerative wellbeing is identified with various human rights, including the privilege to life, the privilege to be free from torment, the privilege to wellbeing, the privilege to protection, the privilege to training, and the disallowance of segregation. Sexual and regenerative wellbeing and rights or SRHR is the idea of human rights connected to sexuality and generation. It is a mix of four fields that in a few settings are pretty much particular from each other, however less so or not in the slightest degree in different settings. These four fields are sexual wellbeing, sexual rights, regenerative wellbeing and conceptive rights. In the idea of SRHR, these four fields are dealt with as isolated however characteristically entwined.

Track 14: Gynecologic Surgery

Gynecologic Surgery is giving a fundamental, peer-assessed data for clinical articles managing all parts of agent and office gynecology. "Gynecological Surgery", established in 2004, is the first and head peer-surveyed logical diary devoted to all parts of research, advancement, and preparing in gynecological surgery Gynecological surgery alludes to surgery on the female conceptive framework. It incorporates strategies for amiable conditions, malignancy, fruitlessness, and incontinence. Gynecological surgery may once in a while be performed for elective or restorative purposes. Also this field is quickly changing because of new advancements and developments in endoscopy, apply autonomy, imaging and other interventional systems. Gynecological surgery is presently envelops every surgical intercession relating to ladies' wellbeing, including urogynecology, oncology and fetal surgery.

Track15: Clinical Gynecology Oncology

As discussed in many Gynecologic events and meetings occurring in the worldwide, it is stated that around 70,000 women are diagnosed with gynecologic cancers in the USA, and half of those were uterine cancer diagnoses with deaths of 7,000 women per year. Ovarian cancer is found to be the 2nd most common gynecologic cancer with around 24,000 new cases every year, leading to 17,000 deaths per year. Mortality of cases in cervical cancer have been decreased as Pap smears have become common in place. however, there are about 11,000 diagnoses every year in which about 4,400 women die from this disease every year 4,300 women are being diagnosed with vulvar cancer each year, in which there is about 900 deaths among them. Vaginal cancer account for about 2,500 diagnoses each year causing about 800 deaths. Every woman is at risk a gynecologic cancer. It is estimated that there will be around 97,000 new cases diagnosed and approximately causing 35,000 deaths from gynecologic cancers in the USA during the year 2015 stated as per The American Cancer Society, in which Uterine cancer may have the large portion of about 60% cases with an estimated mortality rate of approximately 18%. The Ovarian cancer has the highest mortality rate at 60%.

Track 16: Gynecology Disorders

Gynecologic pathology is the restorative pathology subspecialty managing the review and analysis of sickness including the female genital tract. A doctor who hones gynecologic pathology is a gynecologic pathologist. The term begins from the Greek gyno-(gynaikos) signifying "lady" and the postfix - ology, signifying "investigation of". Gestational trophoblastic malady (GTD) is the general name for a gathering of uncommon tumors that happen amid pregnancy in the fetalchorion, GTD can happen in any sort of pregnancy which is quite often reparable if discovered ahead of schedule in Oncology Gynecology Pathogenesis. Uterine leiomyosarcoma (LMS) is an uncommon uterine harm it is a forceful tumor connected with a high danger of repeat and passing, paying little mind to stage. Choriocarcinoma is a disease that grows most regularly from strange placenta and it is about 100% reparable if fitting chemotherapy is managed after the tumor mass is isolated from inside the uterus.

Track 17: Adolescent Gynecology

Pre-adult Gynecology is a companion assessed restorative diary covering gynecology as it identifies with the fields of pediatrics and juvenile medication. It was set up in 1988 as Adolescent and Pediatric Gynecology, acquiring its present name in 1996. It is distributed six times each year by Elsevier, which has distributed the diary since 1988; it is likewise the official diary of the North American Society for Pediatric and Adolescent Gynecology. The supervisor in-boss is Joseph S. Sanfilippo (Magee-Womens Hospital of UPMC). As per the Journal Citation Reports, the diary has a 2014 effect element of 1.683.

4th International Conference on Sexual & Reproductive Health and Family Planning, April 17-18, 2019 | New York, USA; International Conference on Womens Health, Reproduction and Fertility, May 16-17, 2019 Dubai, UAE; 2nd International Meeting on Gynecology and Obstetrics Pathology, November 19-20, 2018 Paris, France; 2nd World Congress on Fetal and Maternal Medicine, July 24-25, 2019 Kyoto, Japan; World Congress on Internal Medicine, Emergency Medicine for the Primary Care, August 14-15, 2019 | Tokyo, Japan; 4th International Conference on Midwifery and Womens Health; October 15-16, 2018 Athens, Greece; International Conference on Frontiers in Gynecologic Cancers, November 07-08, 2018 Singapore; Global Annual Midwifery Congress, February 26-27, 2019 Osaka, Japan; World Congress on Pediatric and Neonatal Nursing, March 1-2, 2019 Tokyo, Japan; 8th World Congress on Midwifery and Womens Health, March 18-19, 2019 Sydney, Australia; 21st Annual Congress on Neonatal and Pediatric Nursing, April 01-02, 2019 Auckland, New Zealand; 2nd Annual Conference on Pediatric Nursing and Healthcare, April 15-16, 2019 Dubai, UAE

Track 18: Gynecologic Cancers: Case Report

It is stated that around 70,000 women are diagnosed with gynecologic cancers in the USA, and half of those were uterine cancer diagnoses with deaths of 7,000 women per year. Ovarian cancer is found to be the 2nd most common gynecologic cancer with around 24,000 new cases every year, leading to 17,000 deaths per year. Mortality of cases in cervical cancer have been decreased as Pap smears have become common in place. however, there are about 11,000 diagnoses every year in which about 4,400 women die from this disease every year. 4,300 women are being diagnosed with vulvar cancer each year, in which there is about 900 deaths among them. Vaginal cancer account for about 2,500 diagnoses each year causing about 800 deaths. Every woman is at risk a gynecologic cancer. It is estimated that there will be around 97,000 new cases diagnosed and approximately causing 35,000 deaths from gynecologic cancers in the USA during the year 2015 stated as per The American Cancer Society, in which Uterine cancer may have the large portion of about 60% cases with an estimated mortality rate of approximately 18%. The Ovarian cancer has the highest mortality rate at 60%.

Track 19: Advances in Obstetrics and Gynecology

Throughout each phase of your lifecycle: Wellness, sickness and times of change, we must be vigilant about your healthcare. Gynecology deals with any disease concerning the reproductive organs: fallopian tubes, cervix, uterus, ovaries and vagina. A gynecologist may also treat related problems in the urinary system since these are closely related to female reproductive organs. The obstetrician deal with the complications of childbirth and ensures both mother and baby is safely guided through all of the phases of pregnancy and childbirth. Both gynecologist & obstetrician play a vital role in the women health. Women need reproductive health care during every stage of life and concern with gynecologist is the first step towards comprehensive, ongoing health and wellness management. Researcher’s focused on overcoming infertility, improving health care for both non-pregnant and pregnant women, combating gynecologic cancers, and easing the menopausal transition in women and many more.

Track 20: Women Reproductive Cancers

As discussed in many Gynecologic events and meetings occurring in the worldwide, it is stated that around 70,000 women are diagnosed with gynecologic cancers in the USA, and half of those were uterine cancer diagnoses with deaths of 7,000 women per year. Ovarian cancer is found to be the 2nd most common gynecologic cancer with around 24,000 new cases every year, leading to 17,000 deaths per year. Mortality of cases in cervical cancer have been decreased as Pap smears have become common in place. however, there are about 11,000 diagnoses every year in which about 4,400 women die from this disease every year... 4,300 women are being diagnosed with vulvar cancer each year, in which there is about 900 deaths among them. Vaginal cancer account for about 2,500 diagnoses each year causing about 800 deaths. Every woman is at risk a gynecologic cancer. It is estimated that there will be around 97,000 new cases diagnosed and approximately causing 35,000 deaths from gynecologic cancers in the USA during the year 2015 stated as per The American Cancer Society, in which Uterine cancer may have the large portion of about 60% cases with an estimated mortality rate of approximately 18%. The Ovarian cancer has the highest mortality rate at 60%.

Track 21: Medicated Intrauterine Devices

Intrauterine device (IUD) is a small, flexible plastic frame to be inserted into the uterine cavity. It mainly work by changing the intra-uterine environment and making it spermicidal. Non-medicated IUD cause a sterile inflammatory response by producing a tissue injury of minor degree but enough to be spermicidal. Hormone releasing IUD add progesterone effect on endometrium to the foreign body reaction. The endometrium becomes decidualized with atrophy of glands. The progesterone IUD does not increase the serum progesterone level
and mainly acts by inhibition of implantation, sperm-capacitation and survival. Levonorgestrel IUD produces serum concentrations of the progestin half those of Norplant and therefore, ovarian follicular development and ovulation is
not inhibited. The LNG-20 IUD decreases the blood loss (by about 40-50%) and dysmenorrhea.

Global Gynecological Devices Market

The global gynecological devices market is marked by a high degree of fragmentation due to the presence of numerous large manufacturers, reports Transparency Market Research (TMR) in a new business intelligence study. This leaves ample scope for market consolidation in the near future. Top companies like Boston Scientific Corporation, Cooper Surgical, and Olympus Corporation hold distinction on account of their widespread product portfolio and geographical outreach. These companies are struggling to introduce non-invasive devices to serve a larger consumer base which will eventually help to expand their geographical outreach.

The increasing demand for medical help for women-centric health issues is bringing in immense scope for growth in the gynecological device market. The small regional players play an important role and hold a significantly higher share in the gynecological device market. The increasing entry barriers and stringent rules and regulations for approval of a product are limiting the entry of new companies. Insufficient funding from venture capitalists is also creating a challenging situation for the entrance of newer companies.

As per projections of a TMR report, the global gynecological devices market will clock 4.8% CAGR between 2017 and 2023. This will translate opportunities in the market to generate a revenue of US$22,589.9 mn by 2023 from US$17,015.9 mn in 2017. In terms of device type, gynecological surgical devices hold prominence in the market. The rising prevalence of single incision laparoscopic surgeries and advances in conventional endoscopic surgeries account for advances in gynecological surgical instruments. Geography-wise, North America is a lucrative market for gynecological devices due to the early adoption of advanced gynecological devices.

Product Insights

Based on the product type, the global market is segmented into gynecological imaging devices, surgical devices, and hand instruments. Surgical devices dominated the market with largest share in 2015. High usage of endoscopy devices and female contraceptives is the factor which can be attributable to the largest share.

The need for highly durable and easily autoclavable surgical instruments has been growing increasingly owing to the growing number of surgical procedures globally. Advancement in technology and introduction of highly efficient devices which can provide quick and accurate diagnosis and minimize the operating time are the factors expected to give a boost to the market growth in the upcoming years.

Global market for Women’s Health

The global market for women’s health therapeutics will grow from nearly $33.0 billion in 2015 to nearly $40.6 billion by 2020, with a compound annual growth rate (CAGR) of 4.2% for the period of 2015-2020.

The infertility treatment devices market is expected to reach USD 3,698.92 Million by 2020 from USD 1,822.32 Million in 2015, at a CAGR of 15.21%. Infertility treatment devices are used in assisted reproductive technologies (ART) like in vitro fertilization, intracytoplasmic sperm injection, and surrogacy for the treatment of infertility.

Related Societies:

· The Association of Physician Assistants in Obstetrics and Gynecology

· Association of Professors of Gynecology and Obstetrics

· American Association of Gynecologic Laparoscopists.

· American College of Obstetricians & Gynecologists

· Central Association of Obstetricians and Gynecologists

· Gynecologic Cancer Foundation

· Society of Gynecologic Oncologists (SGO)

· The European Society of Contraception and Reproductive Health

· The International Federation of Pediatric and Adolescent Gynecology

· International Urogynecology Association (IUGA)

· German Foundation for World Population

· The Association of Physician Assistants in Obstetrics and Gynecology

· Association of Professors of Gynecology and Obstetrics

· American Association of Gynecologic Laparoscopists.

· American College of Obstetricians & Gynecologists

· Central Association of Obstetricians and Gynecologists

· Bahrain Women Association for Human Development

· Middle East Fertility Society (MEFS)

· Bahrain Young Ladies Association

· Syrian American Medical Society

· Syria Expatriate Medical Associations, Association of Women Balqa

· Women’s Union Al – Mafraq

There are different requirements to obtain a Visa to enter Europe or other countries. Meeting all visa and customs requirements is an individual responsibility of each participant. Please consult the European Embassy in your country to find out whether you require a visa, and if so, what requirements are set forth for obtaining it. Some embassies may request a conference attendee to present a letter from the Conference to verify their intentions to attend that specific conference. It may also be necessary to verify that the requester has paid the registration fee in full.

Visa applications are currently subject to a greater degree of scrutiny than in the past. Many applicants may be required to appear in person for an interview as a part of the visa process. Applicants affected by these procedures are informed of the need for additional screening at the time they submit their application and are being advised to expect delays. Therefore, attendees should be advised to apply no later than 3 months prior to the conference.

Conferenceseries LLC Ltd guidelines for providing visa letters are as follows:

Visa letters should only be issued to:

· People the committee knows

· Speakers/Presenters

· Committee members

· Attendees who have paid their registration fee in full or as decided by the committee members

Visa letters should state the following facts:

· Conference title, dates and location

· That the requester has paid the required registration fee in full

· Verify that the credit card clears before providing letter

· If they are either a committee member, speaker or presenter

To simplify the request process for the attendees and organizers you need to request for visa letters for the conference once you are done with registration. Official invitation letter along with payment receipt will be mailed to you within 24-48 hours of your confirmation.

For any queries feel free to send us an email at gynecology@meetingsfinder.org and we shall assist you with more information…

Top 6 Reasons Why You Should Attend Gynecology 2019?

1. Intensive CME & CPD Training.

2. Best Panelists and Keynote Speakers

3. Innovative Treatment Techniques in the field of Gynecology

4. Professional Networking

5. In-Person Conversation Opportunities

6. Getting beyond the headlines

10 Best Things To Do While You Travel To Paris

1. Walk along Champs Elysée

2. Get a picture with the beautiful Arc de Triomphe.

3. Shop till you drop

4. Stroll along the Seine.

5. Explore The Hidden Gems of Paris

6. Visit the Eiffel Tower

7. Try the delicious varieties of French food.

8. Discover the Louvre

9. Visit the Luxembourg Gardens

10. Check out the nightlife at Oberkampf

Important Fundamentals To Know While You’re Travelling

Currency:

The official currency of Portugal is the Euro (€). Major credit cards are accepted in most hotels, shops and restaurants. Money can be changed at the main exchange bureaus, international airports, major bank and most large hotels.

Time Zone:

The main city of France uses and Central European Summer Time. The daylight saving time is known to be observed in the Metropolitan city of France from the last Sunday in March (02:00 CET) to the last Sunday in October (03:00 CEST). Along with its overseas territories, France uses 12 different time zones, more than any other country in the world.France is known to have twelve time zones including those of Metropolitan France, French Guiana and numerous islands, inhabited and uninhabited.

Airport:

The two main airports of the city Paris are Charles de Gaulle and Orly. Both are well served by public transport. Paris Beauvais is much further from the city, and requires a longer and more expensive transfer. Orly is the closest to the city, and

1. 1972- The development and adoption of real-time ultrasound was a revolutionary achievement. Ultrasound-guided amniocentesis was first described in 1972, 14 years after Ian Donald’s seminal paper introducing obstetric ultrasound was published in the Lancet.

2. 2003- MOMS (Management of Myelomeningocele Study) was launched.

3. 2012- The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine support cell-free DNA screening for women at increased risk of fetal aneuploidy.

4. 2013- Preterm birth rate drops to 11.4%

5. 2014: Diabetes incidence marks a 4-fold increase since 1980

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	November 14-15, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View